<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0119994</article-id>
<article-id pub-id-type="publisher-id">PONE-D-14-29621</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Analysis of Pharmacogenomic Variants Associated with Population Differentiation</article-title>
<alt-title alt-title-type="running-head">Pharmacogenomic Variants Associated with Population Differentiation</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Yeon</surname>
<given-names>Bora</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Ahn</surname>
<given-names>Eunyong</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Kyung-Im</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>In-Wha</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Oh</surname>
<given-names>Jung Mi</given-names>
</name>
<xref rid="aff002" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Park</surname>
<given-names>Taesung</given-names>
</name>
<xref rid="aff001" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff003" ref-type="aff"><sup>3</sup></xref>
<xref rid="cor001" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Interdisciplinary Program in Bioinformatics, Seoul National University, Gwanak-ro, Gwanak-gu, Seoul, Korea</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>College of Pharmacy, Seoul National University, Gwanak-ro, Gwanak-gu, Seoul, Korea</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Statistics, Seoul National University, Seoul, Korea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Timpson</surname>
<given-names>Nicholas John</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>University of Bristol, UNITED KINGDOM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: KIK IWK JMO TP. Performed the experiments: BY KIK IWK JMO EA TP. Analyzed the data: BY KIK IWK JMO EA TP. Wrote the paper: BY KIK IWK JMO EA TP.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">tspark@stats.snu.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>3</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<issue>3</issue>
<elocation-id>e0119994</elocation-id>
<history>
<date date-type="received">
<day>2</day>
<month>7</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>3</day>
<month>2</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-year>2015</copyright-year>
<copyright-holder>Yeon et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0119994" xlink:type="simple"/>
<abstract>
<p>In the present study, we systematically investigated population differentiation of drug-related (DR) genes in order to identify common genetic features underlying population-specific responses to drugs. To do so, we used the International HapMap project release 27 Data and Pharmacogenomics Knowledge Base (PharmGKB) database. First, we compared four measures for assessing population differentiation: the chi-square test, the analysis of variance (ANOVA) F-test, F<sub>st</sub>, and Nearest Shrunken Centroid Method (NSCM). F<sub>st</sub> showed high sensitivity with stable specificity among varying sample sizes; thus, we selected F<sub>st</sub> for determining population differentiation. Second, we divided DR genes from PharmGKB into two groups based on the degree of population differentiation as assessed by F<sub>st</sub>: genes with a high level of differentiation (HD gene group) and genes with a low level of differentiation (LD gene group). Last, we conducted a gene ontology (GO) analysis and pathway analysis. Using all genes in the human genome as the background, the GO analysis and pathway analysis of the HD genes identified terms related to cell communication. “Cell communication” and “cell-cell signaling” had the lowest Benjamini-Hochberg’s q-values (0.0002 and 0.0006, respectively), and “drug binding” was highly enriched (16.51) despite its relatively high q-value (0.0142). Among the 17 genes related to cell communication identified in the HD gene group, five genes (<italic>STX4</italic>, <italic>PPARD</italic>, <italic>DCK</italic>, <italic>GRIK4</italic>, and <italic>DRD3</italic>) contained single nucleotide polymorphisms with F<sub>st</sub> values greater than 0.5. Specifically, the F<sub>st</sub> values for rs10871454, rs6922548, rs3775289, rs1954787, and rs167771 were 0.682, 0.620, 0.573, 0.531, and 0.510, respectively. In the analysis using DR genes as the background, the HD gene group contained six significant terms. Five were related to reproduction, and one was “Wnt signaling pathway,” which has been implicated in cancer. Our analysis suggests that the HD gene group from PharmGKB is associated with cell communication and drug binding.</p>
</abstract>
<funding-group>
<funding-statement>This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Republic of Korea (MSIP) (2012R1A3A2026438, 2008–0062618, 2013M3A9C4078158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="5"/>
<page-count count="17"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability" xlink:type="simple">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the manuscript, from the HapMap Phase III database (<ext-link ext-link-type="uri" xlink:href="http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/hapmap3_r3/" xlink:type="simple">http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/hapmap3_r3/</ext-link>), and from the ‘genes.zip’ download link on the Pharmacogenomics Knowledge Base database download site (<ext-link ext-link-type="uri" xlink:href="https://www.pharmgkb.org/downloads/" xlink:type="simple">https://www.pharmgkb.org/downloads/</ext-link>).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>The DNA sequence of the 3-billion-nucleotide-long human genome varies by approximately 0.1% between individuals. Surprisingly, this small difference in the DNA sequence accounts for individual differences in appearance, behavior, and even disease status. Furthermore, this difference in DNA sequence can have an even larger effect among ethnic populations. Genetic divergence between ethnic groups is called population differentiation (PD). PD results from genetic factors that enforce natural selection, genetic drift, or gene flow. Moreover, genes related to Mendelian diseases have a significant excess of single-nucleotide polymorphisms (SNPs) with high levels of PD, and the incidence of and susceptibility to these diseases differ among populations [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>].</p>
<p>Several recent studies on PD have focused on genetic variations. Myles <italic>et al</italic>. attempted to identify SNPs accounting for disease-associated PD [<xref rid="pone.0119994.ref002" ref-type="bibr">2</xref>]. However, they found no disease-associated SNPs that were more significantly differentiated than randomly selected SNPs in the genome among populations. Nevertheless, the frequencies of risk alleles for disease-associated SNPs showed substantial variation across human populations. Barreiro <italic>et al</italic>. analyzed the degree of PD with 2.8 million SNPs and discovered the role of natural selection in shaping PD [<xref rid="pone.0119994.ref003" ref-type="bibr">3</xref>]. Wu and Zhang also performed a genome-wide study of PD and found that many groups of genes had higher degrees of PD [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>]. Specifically, PD existed on some loci associated with phenotypes (e.g., hair growth and pigmentation) that are well known to vary across populations.</p>
<p>PD has also been investigated in pharmacogenomic studies [<xref rid="pone.0119994.ref004" ref-type="bibr">4</xref>]. For example, the response to warfarin, one of the most widely studied drugs, depends not only on genetic variants [<xref rid="pone.0119994.ref005" ref-type="bibr">5</xref>] but also on population [<xref rid="pone.0119994.ref006" ref-type="bibr">6</xref>]. As a result, some authors have suggested that warfarin be dosed according to the patient’s race. In fact, Pavani <italic>et al</italic>. suggested a linear model for optimizing population-specific warfarin dose [<xref rid="pone.0119994.ref007" ref-type="bibr">7</xref>]. Huang <italic>et al</italic>. identified SNPs contributing to etoposide-induced cytotoxicity in a genome-wide association study (GWAS) using International HapMap cell lines, and they demonstrated different genotypes associated with cytotoxicity between two populations [<xref rid="pone.0119994.ref008" ref-type="bibr">8</xref>]. In order to investigate PD of DR genes, we analyzed data from two databases: International HapMap release 27 (phase II + III) [<xref rid="pone.0119994.ref009" ref-type="bibr">9</xref>] and Pharmacogenomics Knowledge Base (PharmGKB) [<xref rid="pone.0119994.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0119994.ref011" ref-type="bibr">11</xref>], the most widely used DR database. Originally, HapMap release 27 contained 11 subpopulations. However, the allele frequencies of populations in the same ethnic groups are highly correlated [<xref rid="pone.0119994.ref012" ref-type="bibr">12</xref>], and there is lack of genotypic information in some populations. Therefore, we used the following subpopulations: European, African, and Asian from Japan and China.</p>
<p>There are several measures for determining the distance among populations. Among them, F<sub>st</sub> is the most widely used measure to determine PD. Akey <italic>et al</italic>. [<xref rid="pone.0119994.ref013" ref-type="bibr">13</xref>] and Barreiro <italic>et al</italic>. [<xref rid="pone.0119994.ref003" ref-type="bibr">3</xref>] used Weir and Cockerham’s estimate, an unbiased estimate of F<sub>st</sub> [<xref rid="pone.0119994.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0119994.ref015" ref-type="bibr">15</xref>]. Casto <italic>et al</italic>. used four measures: (i) δ, the difference in allele frequency between two groups; (ii) integrated haplotype score (iHS), which characterizes the lengths of the haplotypes surrounding each allele of a SNP [<xref rid="pone.0119994.ref016" ref-type="bibr">16</xref>]; (iii) latitude/longitude correlation (LLC), which describes how closely changes in a SNP’s allele frequency follow geographical coordinates; and (iv) F<sub>st</sub>, which shows variation in allele frequency among populations [<xref rid="pone.0119994.ref017" ref-type="bibr">17</xref>]. Park <italic>et al</italic>. used the Nearest Shrunken Centroid Method (NSCM) [<xref rid="pone.0119994.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0119994.ref019" ref-type="bibr">19</xref>], which was originally designed for clustering of microarray data. NSCM has been proposed for solving the classification problem with a large number of features and it was also applied to the analysis of population differentiation in SNPs via Hapmap data [<xref rid="pone.0119994.ref018" ref-type="bibr">18</xref>]. Han <italic>et al</italic>. modified F<sub>st</sub> for use with allele frequency data with unbalanced sample sizes [<xref rid="pone.0119994.ref020" ref-type="bibr">20</xref>].</p>
<p>In order to investigate PD of DR genes, we first compared four measures for assessing population differentiation: the chi-square test, the ANOVA F-test, F<sub>st</sub>, and NSCM. F<sub>st</sub> showed high sensitivity with stable specificity among varying sample sizes; thus, we selected F<sub>st</sub> for determining population differentiation. We then divided DR genes from PharmGKB into two groups based on the degree of population differentiation as assessed by F<sub>st</sub>: genes with high a level of differentiation (HD gene group) and genes with a low level of differentiation (LD gene group). Finally, we conducted a gene ontology (GO) analysis and pathway analysis.</p>
<p>Several studies have investigated PD associated with individual drugs [<xref rid="pone.0119994.ref004" ref-type="bibr">4</xref>]. In the present study, we systematically studied PD of drug-related (DR) genes by simultaneously considering all reported DR genes. This integrative approach may help clarify the inconsistent genetic features of drug response associated with PD. Furthermore, our findings will improve the study and prediction of drug responses that differ among populations due to genetic stratification.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title>1. Measures of PD</title>
<p>Since the measures of PD are not always consistent, it is difficult to choose an appropriate measure for PD. Thus, we first performed a comparison analysis in order to identify the highest performing measures in our study. We compared the following four measures: Weir and Cockerham’s F<sub>st</sub> [<xref rid="pone.0119994.ref015" ref-type="bibr">15</xref>], the sum of square of <italic>d</italic><sub><italic>i</italic></sub> from NSCM, the chi-square test, and analysis of variance (ANOVA) F-test. Other measures were excluded for the following reasons. δ is used for comparisons between two populations; however, we compared PD among three populations. In our research, we tried to evaluate which SNPs are highly differentiated but iHS shows whether SNPs are differently selected. Therefore, the results via iHS are not concordant with the results from other measures. Moreover, Ferrer-Admetlla et al. suggest that iHS seems to be affected by the recombination rate [<xref rid="pone.0119994.ref021" ref-type="bibr">21</xref>]. Thus, we would like to exclude iHS from our sensitivity and specificity analysis. LLC was excluded, because latitude and longitude information for each individual was needed to determine PD.</p>
<p>We compared the specificity and sensitivity of these measures using simulation studies. Our comparison study focused on consistency and reliability with respect to the populations’ sample sizes and imbalance in sample sizes among populations. Our comparison revealed that F<sub>st</sub> had the most stable specificity regardless of the variability in sample size and the highest sensitivity as compared to other measures. Thus, we concluded that F<sub>st</sub> was the most appropriate measure of PD for our integrative analysis of International HapMap release 27 and PharmGKB.</p>
<p>The chi-square test is a widely used statistical method for testing the homogeneity of group proportions. In this study, we used it to test whether allele frequencies of the <italic>J</italic> subgroups were equal; the null hypothesis was:
<disp-formula id="pone.0119994.e001">
<alternatives>
<graphic id="pone.0119994.e001g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e001" xlink:type="simple"/>
<mml:math display="block" id="M1" overflow="scroll">
<mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mo>⋯</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>J</mml:mi></mml:msub></mml:mrow>
</mml:math>
</alternatives>
<label>(1)</label>
</disp-formula>
where <italic>p</italic><sub><italic>i</italic></sub> denotes the allele frequency of the <italic>i</italic><sub>th</sub> population. In the chi-square test, 0.05 or the q-value from Benjamini and Hochberg’s method [<xref rid="pone.0119994.ref022" ref-type="bibr">22</xref>] is usually used as the significance level for testing the null hypothesis. Thus, the significance level varies according to <italic>N</italic>.</p>
<p>The model for the ANOVA F-test was:
<disp-formula id="pone.0119994.e002">
<alternatives>
<graphic id="pone.0119994.e002g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e002" xlink:type="simple"/>
<mml:math display="block" id="M2" overflow="scroll">
<mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>μ</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub> <mml:mover accent="true"><mml:mi>o</mml:mi><mml:mo>́</mml:mo></mml:mover><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow/></mml:mover><mml:msub><mml:mi>τ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow>
</mml:math>
</alternatives>
<label>(2)</label>
</disp-formula>
where <italic>a</italic><sub><italic>ij</italic></sub> is the number of the allele (value of 0, 1, or 2) for the <italic>j</italic><sub>th</sub> individual in the <italic>i</italic><sub>th</sub> population. <italic>μ</italic> and <italic>μ</italic>+<italic>τ</italic><sub><italic>i</italic></sub> are the overall mean genotype frequencies within individuals and mean of allele frequencies in the <italic>i</italic><sub>th</sub> population, respectively. <italic>ε</italic><sub><italic>ij</italic></sub> is the error term. Thus, by testing H<sub>0</sub>:<italic>τ</italic><sub><italic>i</italic></sub> = 0, for <sup>∀</sup><italic>i</italic>, we could test whether the allele frequencies of subgroups were equal to one another assuming a Gaussian distribution.</p>
<p>We used Weir’s F<sub>st</sub> estimate<inline-formula id="pone.0119994.e003"><alternatives><graphic id="pone.0119994.e003g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e003" xlink:type="simple"/><mml:math display="inline" id="M3" overflow="scroll"><mml:mrow><mml:mover><mml:mi>θ</mml:mi><mml:mo>∧</mml:mo></mml:mover></mml:mrow></mml:math></alternatives></inline-formula> [<xref rid="pone.0119994.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0119994.ref015" ref-type="bibr">15</xref>], an unbiased estimator of F<sub>st</sub>. <italic>n</italic><sub><italic>i</italic></sub> denotes the sample size of the <italic>i</italic><sub>th</sub> subpopulation (i = 1,…,<italic>s</italic>). n = Σ<italic>n</italic><sub><italic>i</italic></sub> denotes the total sample size. <inline-formula id="pone.0119994.e004"><alternatives><graphic id="pone.0119994.e004g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e004" xlink:type="simple"/><mml:math display="inline" id="M4" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover></mml:mrow></mml:math></alternatives></inline-formula>denotes the observed allele frequency of the <italic>i</italic><sub>th</sub> subpopulation, and <inline-formula id="pone.0119994.e005"><alternatives><graphic id="pone.0119994.e005g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e005" xlink:type="simple"/><mml:math display="inline" id="M5" overflow="scroll"><mml:mrow><mml:mover accent="true"><mml:mi>p</mml:mi><mml:mo>¯</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:msup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mo>​</mml:mo></mml:msup><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mover accent="true"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo>/</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math></alternatives></inline-formula> denotes the weighted average of allele frequency.
<disp-formula id="pone.0119994.e006">
<alternatives>
<graphic id="pone.0119994.e006g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e006" xlink:type="simple"/>
<mml:math display="block" id="M6" overflow="scroll">
<mml:mrow><mml:mover accent="true"><mml:mi>θ</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>MSP</mml:mtext><mml:mo>−</mml:mo><mml:mtext>MSG</mml:mtext></mml:mrow><mml:mrow><mml:mtext>MSP</mml:mtext><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mtext>n</mml:mtext><mml:mtext>c</mml:mtext></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext>MSG</mml:mtext></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(3)</label>
</disp-formula>
where
<disp-formula id="pone.0119994.e007">
<alternatives>
<graphic id="pone.0119994.e007g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e007" xlink:type="simple"/>
<mml:math display="block" id="M7" overflow="scroll">
<mml:mrow><mml:mtext>MSP</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>s</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:munderover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>s</mml:mi></mml:munderover><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mover accent="true"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mo>−</mml:mo><mml:mover accent="true"><mml:mi>p</mml:mi><mml:mo>¯</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(4)</label>
</disp-formula>
<disp-formula id="pone.0119994.e008">
<alternatives>
<graphic id="pone.0119994.e008g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e008" xlink:type="simple"/>
<mml:math display="block" id="M8" overflow="scroll">
<mml:mrow><mml:mtext>MSG</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msubsup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>s</mml:mi></mml:msubsup><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:munderover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>s</mml:mi></mml:munderover><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mover accent="true"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mover accent="true"><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo stretchy="true">^</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow>
</mml:math>
</alternatives>
<label>(5)</label>
</disp-formula>
<disp-formula id="pone.0119994.e009">
<alternatives>
<graphic id="pone.0119994.e009g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e009" xlink:type="simple"/>
<mml:math display="block" id="M9" overflow="scroll">
<mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>c</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>s</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:munderover><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>s</mml:mi></mml:munderover><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>s</mml:mi></mml:msubsup><mml:msubsup><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>s</mml:mi></mml:msubsup><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
<label>(6)</label>
</disp-formula>
MSP and MSG represent the observed mean square error of a locus between populations and the observed mean square error of a locus within populations, respectively. <italic>n</italic><sub><italic>c</italic></sub> is the average sample size across <italic>n</italic> samples, correcting for variation in sample size among subpopulations.</p>
<p>We also defined the sum of square of standardized distance to measure PD via NSCM as follows;
<disp-formula id="pone.0119994.e010">
<alternatives>
<graphic id="pone.0119994.e010g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e010" xlink:type="simple"/>
<mml:math display="block" id="M10" overflow="scroll">
<mml:mrow><mml:msub><mml:mrow><mml:mtext>SS</mml:mtext></mml:mrow><mml:mtext>d</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mi>i</mml:mi></mml:munder><mml:msubsup><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow>
</mml:math>
</alternatives>
<label>(7)</label>
</disp-formula>
</p>
<p>It is a representative value for the <italic>k</italic><sub><italic>th</italic></sub> SNP in population <italic>i</italic>, where
<disp-formula id="pone.0119994.e011">
<alternatives>
<graphic id="pone.0119994.e011g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e011" xlink:type="simple"/>
<mml:math display="block" id="M11" overflow="scroll">
<mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>s</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow>
</mml:math>
</alternatives>
<label>(8)</label>
</disp-formula>
Here, <italic>a</italic><sub><italic>ik</italic></sub> denotes the mean of allele frequencies in population <italic>i</italic>; <italic>a</italic><sub><italic>k</italic></sub> denotes the overall mean of allele frequency of SNP <italic>k</italic>, and <inline-formula id="pone.0119994.e012"><alternatives><graphic id="pone.0119994.e012g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e012" xlink:type="simple"/><mml:math display="inline" id="M12" overflow="scroll"><mml:mrow><mml:msub><mml:mi>m</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>n</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac></mml:mrow></mml:msqrt></mml:mrow></mml:math></alternatives></inline-formula>, which makes <italic>m</italic><sub><italic>i</italic></sub>·<italic>s</italic><sub><italic>k</italic></sub> equal to the estimate of standard error for the numerator of <italic>d</italic><sub><italic>ik</italic></sub>·<italic>s</italic><sub>0</sub> was set equal to the median of <italic>s</italic><sub><italic>k</italic></sub> over the set of SNPs to prevent inflation of <italic>d</italic><sub><italic>ik</italic></sub>.</p>
</sec>
<sec id="sec004">
<title>2. GO analysis and pathway analysis of the HD and LD gene groups</title>
<p>We used a gene ontology (GO) analysis to identify biological characteristics of the HD and LD gene groups. We compared each gene group to other functionally annotated genes in HapMap Data [<xref rid="pone.0119994.ref023" ref-type="bibr">23</xref>] and to DR genes in the PharmGKB Database.</p>
<p>Wright proposed the following F<sub>st</sub> categories: (i) F<sub>st</sub> &lt; 0.05, low divergence; (ii) 0.05 &lt; F<sub>st</sub> &lt; 0.15, moderate divergence; (iii) 0.15 &lt; F<sub>st</sub> &lt; 0.25, high divergence; and (iv) F<sub>st</sub> &gt; 0.25, very high divergence [<xref rid="pone.0119994.ref024" ref-type="bibr">24</xref>]. Using Wright’s F<sub>st</sub> criteria, genes containing at least one SNP with an F<sub>st</sub> value greater than 0.25 were considered to have a high level of differentiation (HD gene group) [<xref rid="pone.0119994.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0119994.ref026" ref-type="bibr">26</xref>], while those containing SNPs with F<sub>st</sub> values less than 0.05 were considered to have a low level of differentiation (LD gene group). Additionally, we identified the SNPs with a high level of differentiation from GO analysis results if F<sub>st</sub> greater than 0.5, because this criterion was used for previous studies [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0119994.ref027" ref-type="bibr">27</xref>].</p>
<p>For the GO analysis, SNPs associated with drugs from PharmGKB were annotated into genes. These DR genes were divided into two groups using the F<sub>st</sub> criteria proposed by Wright [<xref rid="pone.0119994.ref024" ref-type="bibr">24</xref>]. From 654 DR SNPs in the HapMap Database, we obtained 160 SNPs with HD and 173 SNPs with LD (<xref rid="pone.0119994.t001" ref-type="table">Table 1</xref>). From these SNPs, 68 genes with HD and 114 genes with LD were derived.</p>
<table-wrap id="pone.0119994.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.t001</object-id>
<label>Table 1</label> <caption><title>Summary of each SNP group.</title></caption>
<alternatives>
<graphic id="pone.0119994.t001g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.t001" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1"/>
<th align="left" rowspan="1" colspan="1">SNPs with high differentiation</th>
<th align="left" rowspan="1" colspan="1">SNPs with low differentiation</th>
<th align="left" rowspan="1" colspan="1">Total</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Count</bold></td>
<td align="left" rowspan="1" colspan="1">160</td>
<td align="left" rowspan="1" colspan="1">173</td>
<td align="left" rowspan="1" colspan="1">654</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Mean (Fst)</bold></td>
<td align="left" rowspan="1" colspan="1">0.364</td>
<td align="left" rowspan="1" colspan="1">0.020</td>
<td align="left" rowspan="1" colspan="1">0.157</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Median (Fst)</bold></td>
<td align="left" rowspan="1" colspan="1">0.344</td>
<td align="left" rowspan="1" colspan="1">0.019</td>
<td align="left" rowspan="1" colspan="1">0.111</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>To investigate the biological differences between the HD and LD gene groups, we performed a GO analysis and a pathway analysis using the Database for Annotation, Visualization and Integrated Discovery (DAVID) [<xref rid="pone.0119994.ref028" ref-type="bibr">28</xref>] v6.7 functional annotation tool. Annotated genes from each group were used as the input, while a list of whole genes in DAVID with at least one annotation in the analyzing categories was used as the background. For the GO analysis, the following three categories were selected: biological process (BP), molecular function (MF), and cellular component (CC) [<xref rid="pone.0119994.ref029" ref-type="bibr">29</xref>]. For the pathway analysis, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was used [<xref rid="pone.0119994.ref030" ref-type="bibr">30</xref>].</p>
<p>Additional GO and pathway analyses were performed in a similar manner in order to compare genes in the HD gene group to those in the DR gene group. In this case, the DR HD gene group was used as the input for analysis, and the DR gene group was used as the background.</p>
<p>To correct for multiple tests, we used the hypergeometric test from Benjamini-Hochberg’s method [<xref rid="pone.0119994.ref022" ref-type="bibr">22</xref>]. Fold enrichments, defined as the ratios of proportions between the input and background, were calculated for each term. Terms with Benjamini-Hochberg’s q-values of 0.05 or lower were considered significant.</p>
</sec>
</sec>
<sec id="sec005" sec-type="results">
<title>Results</title>
<sec id="sec006">
<title>1. Data collection</title>
<p>We analyzed SNP data from International HapMap Phase II + III, release 27 (<ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org/" xlink:type="simple">http://www.hapmap.org</ext-link>) [<xref rid="pone.0119994.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0119994.ref031" ref-type="bibr">31</xref>]. According to Hapmap consortium, there are distinct three clusters, European, African and Asian from the principal component plot of 11 populations in hapmap3[<xref rid="pone.0119994.ref031" ref-type="bibr">31</xref>]. Therefore, we used three groups based on these three regions. We included 120 Yoruba from Ibadan, Nigeria (YRI), 181 Asians of which are 91 Japanese from Tokyo, Japan (JPT) and 90 Han Chinese from Beijing, China (CHB), and 120 Utah residents with ancestry from northern and western Europe (CEU). We used only founders of CEU and YRI to exclude the related samples. Because International HapMap release 27 consists of a mixture of two phases, each SNP had a different sample size. <xref rid="pone.0119994.g001" ref-type="fig">Fig. 1</xref> shows the sample-size distributions of subpopulations from International HapMap Data. The SNPs from Phase II had smaller sample sizes, while those from Phase III had larger sample sizes (<xref rid="pone.0119994.g001" ref-type="fig">Fig. 1B</xref>). Some SNPs are only genotyped in phase II and others are only genotyped in phase III. In this reason, we only included four populations, which are both in phase II, and III simultaneously to avoid the potential biases due to different settings of each phases.</p>
<fig id="pone.0119994.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Histogram of sample sizes from 654 drug-related SNPs.</title>
<p><bold>A</bold>. Total sample sizes of SNPs. <bold>B</bold>. Sample size of each population of SNPs. CHB and JPT are plotted separately according to the format of the original HapMap Data. SNPs with larger sample sizes are included in Phase III, and SNPs with smaller sample sizes are included in Phase II.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.g001" position="float" xlink:type="simple"/>
</fig>
<p>In addition, Kim et al. (2012) reported that JPT and CHB in Hapmap possess the common genetic information through MDS plot and Fst [<xref rid="pone.0119994.ref032" ref-type="bibr">32</xref>]. Therefore, we merged these two data into one East Asian data. We used allele frequency data of three populations as following: Yoruba in Ibadan, Nigeria (YRI), Utah residents with ancestry from Northern and Western Europe (CEU), and East Asian (EA), which consists of the Han Chinese population in Beijing, China (CHB) and the Japanese population in Tokyo, Japan (JPT). Also, we used only founders of CEU and YRI to exclude the related samples. For pharmacological research, we collected 2595 DR SNPs from PharmGKB (<ext-link ext-link-type="uri" xlink:href="http://www.pharmgkb.org/" xlink:type="simple">http://www.pharmgkb.org</ext-link>) [<xref rid="pone.0119994.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0119994.ref011" ref-type="bibr">11</xref>]. Finally, from these two databases, 654 compatible SNPs among three populations were used for analysis.</p>
</sec>
<sec id="sec007">
<title>2. Comparison of four PD measures using simulation</title>
<p>We selected four PD measures: chi-square test, Weir’s F<sub>st</sub>, ANOVA F-test, and sum of square of <italic>d</italic><sub><italic>i</italic></sub> from NSCM. Since each phase in HapMap release 27 had different sample sizes, we set the sample size <italic>n</italic><sub><italic>i</italic></sub> of the subpopulations as a parameter of the simulation as well as the distance <italic>d</italic> between allele frequencies in order to compare the performance of the four measures. To examine the effect of sample size on these measures, we set <italic>n</italic><sub><italic>i</italic></sub> as follows:</p>
<p>Scenario I: Increased sample sizes (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,100,100), (200,200,200), and (400,400,400).</p>
<p>Scenario II: Unbalanced sample sizes among the subpopulations (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (200,100,100),(100,200,100), and (100,100,200)</p>
<p>For convenience, we assumed equal distance between adjacent alleles and let the distance <italic>d</italic> = <italic>p</italic><sub>2</sub>-<italic>p</italic><sub>1</sub> = <italic>p</italic><sub>3</sub>-<italic>p</italic><sub>2</sub>(<italic>p</italic><sub>1</sub>≤<italic>p</italic><sub>2</sub>≤<italic>p</italic><sub>3</sub>). We generated <italic>p</italic><sub><italic>i</italic></sub> with <italic>d</italic> = 0.1,0.2,0.3 and <italic>p</italic><sub>1</sub> was generated under uniform distribution on [0, min(0.5,1-2d)] (<xref rid="pone.0119994.t002" ref-type="table">Table 2</xref>). Here, we used <italic>min</italic>(0.5,1-2<italic>d</italic>) as the maximum of <italic>p</italic><sub>1</sub> rather than 1 because of the symmetry in allele frequency. If <italic>p</italic><sub>1</sub> is greater than 0.5, then <italic>p</italic><sub>2</sub> and <italic>p</italic><sub>3</sub> are also greater than 0.5, and we can alternatively identify a set of allele frequencies {1-<italic>p</italic><sub>3</sub>,1-<italic>p</italic><sub>2</sub>, <italic>and</italic> 1-<italic>p</italic><sub>1</sub>} instead of {<italic>p</italic><sub>1</sub>, <italic>p</italic><sub>2</sub>, <italic>p</italic><sub>3</sub>}.</p>
<table-wrap id="pone.0119994.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.t002</object-id>
<label>Table 2</label> <caption><title>Examples of data sets.</title></caption>
<alternatives>
<graphic id="pone.0119994.t002g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.t002" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1"><italic>p</italic><sub>1</sub></th>
<th colspan="3" align="center" rowspan="1">d</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">0.1</th>
<th align="left" rowspan="1" colspan="1">0.2</th>
<th align="left" rowspan="1" colspan="1">0.3</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">{0, 0.1, 0.2}</td>
<td align="left" rowspan="1" colspan="1">{0, 0.2, 0.4}</td>
<td align="left" rowspan="1" colspan="1">{0, 0.3, 0.6}</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">0.1</td>
<td align="left" rowspan="1" colspan="1">{0.1, 0.2, 0.3}</td>
<td align="left" rowspan="1" colspan="1">{0.1, 0.3, 0.5}</td>
<td align="left" rowspan="1" colspan="1">{0.1, 0.4, 0.7}</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">0.2</td>
<td align="left" rowspan="1" colspan="1">{0.2, 0.3, 0.4}</td>
<td align="left" rowspan="1" colspan="1">{0.2, 0.4, 0.6}</td>
<td align="left" rowspan="1" colspan="1">{0.2, 0.5, 0.8}</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">0.3</td>
<td align="left" rowspan="1" colspan="1">{0.3, 0.4, 0.5}</td>
<td align="left" rowspan="1" colspan="1">{0.3, 0.5, 0.7}</td>
<td align="left" rowspan="1" colspan="1">{0.3, 0.6, 0.9}</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">0.4</td>
<td align="left" rowspan="1" colspan="1">{0.4, 0.5, 0.6}</td>
<td align="left" rowspan="1" colspan="1">{0.4, 0.6, 0.8}</td>
<td align="left" rowspan="1" colspan="1">{0.4, 0.7, 1.0}</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">0.5</td>
<td align="left" rowspan="1" colspan="1">{0.5, 0.6, 0.7}</td>
<td align="left" rowspan="1" colspan="1">{0.5, 0.7, 0.9}</td>
<td align="left" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
<p>From these conditions, we generated 200 sets of genotype frequency data from three binomial distributions under Hardy-Weinberg Equilibrium (HWE): binomial distribution<inline-formula id="pone.0119994.e013"><alternatives><graphic id="pone.0119994.e013g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e013" xlink:type="simple"/><mml:math display="inline" id="M13" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>, binomial distribution (<italic>n</italic><sub><italic>i</italic></sub>, 2<italic>p</italic><sub><italic>i</italic></sub><italic>q</italic><sub><italic>i</italic></sub>) and binomial distribution<inline-formula id="pone.0119994.e014"><alternatives><graphic id="pone.0119994.e014g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e014" xlink:type="simple"/><mml:math display="inline" id="M14" overflow="scroll"><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>q</mml:mi><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>. We then calculated the four PD measures. <xref rid="pone.0119994.g002" ref-type="fig">Fig. 2</xref> shows the box plots representing the distributions of the measures from two scenarios. As <italic>d</italic> increased, the box sizes of the chi-square test, ANOVA F-test, and NSCM increased, while those of F<sub>st</sub> did not. All measures increased as <italic>d</italic> increased. As the total sample size increased, the <italic>p</italic>-values from the chi-square test and ANOVA F-test decreased, while those from F<sub>st</sub> and SS<sub>d</sub> from NSCM did not change significantly (<xref rid="pone.0119994.g002" ref-type="fig">Fig. 2A</xref>).</p>
<fig id="pone.0119994.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Boxplots representing four measures of simulation data with an increase in <italic>d</italic>.</title>
<p><bold>A.</bold> Variation of distributions due to increase in sample sizes (Case I). <bold>B.</bold> Variation of distributions due to bias of sample sizes (Case II). For both cases, the <italic>x</italic>-axis denotes the distance <italic>d</italic>, and the <italic>y</italic>-axis and denotes the following measures: -log<sub>10</sub> <italic>Pvalue</italic> for chi-square test and ANOVA F-test; Weir and Cockerham’s F<sub>st</sub> estimates for F<sub>st</sub>; <inline-formula id="pone.0119994.e015"><alternatives><graphic id="pone.0119994.e015g" position="anchor" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.e015" xlink:type="simple"/><mml:math display="inline" id="M15" overflow="scroll"><mml:mrow><mml:msup><mml:mstyle mathsize="140%" displaystyle="true"><mml:mo>∑</mml:mo></mml:mstyle><mml:mo>​</mml:mo></mml:msup><mml:msubsup><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:math></alternatives></inline-formula> for NSCM.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.g002" position="float" xlink:type="simple"/>
</fig>
<p><xref rid="pone.0119994.g002" ref-type="fig">Fig. 2B</xref> shows the effect of unbalanced sample size. All measures tended to increase as <italic>d</italic> increased. All measures showed higher levels of differentiation when <italic>n</italic><sub>1</sub> or <italic>n</italic><sub>3</sub> was unbalanced (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (200,100,100)·(100,100,200) than when <italic>n</italic><sub>2</sub> was unbalanced (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,200,100). This was because sample sizes <italic>n</italic><sub>1</sub> and <italic>n</italic><sub>3</sub> of the subpopulation with extreme values of allele frequencies <italic>p</italic><sub>1</sub> and <italic>p</italic><sub>3</sub> had large effects on the PD measures.</p>
</sec>
<sec id="sec008">
<title>3. Comparison of the sensitivity and specificity of four PD measures</title>
<p>We simulated additional data from the same sample-size condition <italic>n</italic><sub><italic>i</italic></sub> as described above. <italic>p</italic><sub>1</sub> was generated under uniform distribution on [0, min(0.5,1-2d)]. In these simulations, <italic>d</italic> = 0 indicates the null hypothesis, and other values of <italic>d</italic> indicate the alternative hypothesis. For a given <italic>d</italic> and <italic>n<sub>i</sub></italic>, we generated 100 datasets from the three binomial distributions under HWE. We calculated the specificity (when <italic>d</italic> = 0) and the sensitivity (when <italic>d</italic> = 0.05,0.1,…,0.3) by counting the true negatives and true positives and repeated this step 100 times to calculate the average sensitivity and specificity.</p>
<p>The chi-square test and ANOVA F-test depended on total sample sizes, as indicated by the specificities calculated under the null hypothesis (<italic>d</italic> = 0) for Scenario I (<xref rid="pone.0119994.g003" ref-type="fig">Fig. 3</xref>). When the total sample sizes were small, the chi-square test and ANOVA F-test showed high specificities; however, the specificities fell to 92% as the sample size increased. This reflects a general characteristic of test statistics, where the test statistic tends to reject the null hypothesis more when the sample size increases. For Scenario II, all four measures yielded high specificities that were close to one.</p>
<fig id="pone.0119994.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Specificities (%) of each measure from simulation data under H<sub>0</sub>:<italic>d</italic> = 0 due to an increase in sample size (Scenario I).</title>
<p>The chi-square test and ANOVA F-test are similar, and F<sub>st</sub> and SS<sub>d</sub> from NSCM are nearly identical. Blue line: chi-square test; red line: F<sub>st</sub>; black dotted line: ANOVA F-test; green dotted line: SS<sub>d</sub> from NSCM.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.g003" position="float" xlink:type="simple"/>
</fig>
<p>In general, the sensitivity increased for all measures as the sample size increased. Still, NSCM consistently yielded the lowest sensitivity. The sensitivities of the chi-square test and ANOVA F-test increased as the total sample size increased. When the sample size was small, F<sub>st</sub> had the highest sensitivity among the measures (<xref rid="pone.0119994.g004" ref-type="fig">Fig. 4A</xref>). When the sample size was moderate or large, the chi-square test and the ANOVA F-test had the highest sensitivities (<xref rid="pone.0119994.g004" ref-type="fig">Fig. 4B, 4C</xref>). Note that F<sub>st</sub> yielded sensitivity and specificity that were robust to sample size, while the other measures did not. <xref rid="pone.0119994.g005" ref-type="fig">Fig. 5</xref> shows the sensitivities from Scenario II. For the same <italic>d</italic>, specificities were lower when (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,200,100) than other situations, similar to the result shown in <xref rid="pone.0119994.g002" ref-type="fig">Fig. 2B</xref>. NCSM had the lowest sensitivity. The chi-square test and ANOVA F-test had approximately equal sensitivities, while F<sub>st</sub> had slightly lower sensitivities.</p>
<fig id="pone.0119994.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Sensitivities (%) of each measure from simulation data under H<sub>0</sub>:<italic>d</italic> = 0.05,0.1…,0.3 due to an increase in sample size (Scenario I).</title>
<p><bold>A</bold>. (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,100,100). <bold>B</bold>. (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (200,200,200). <bold>C</bold>. (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,100,100). Blue line: chi-square test; red line: F<sub>st</sub>; black dotted line: ANOVA F-test; green dotted line: SS<sub>d</sub> from NSCM.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.g004" position="float" xlink:type="simple"/>
</fig>
<fig id="pone.0119994.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Sensitivities (%) of each measure from simulation data under H<sub>0</sub>:<italic>d</italic>=0.05,0.1…,0.3 due to bias in sample size (Scenario II).</title>
<p>A. (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (200,100,100). <bold>B</bold>. (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,200,100). <bold>C</bold>. (<italic>n</italic><sub>1</sub>,<italic>n</italic><sub>2</sub>,<italic>n</italic><sub>3</sub>) = (100,100,200). Blue line: chi-square test; red line: F<sub>st</sub>; black dotted line: ANOVA F-test; green dotted line: SS<sub>d</sub> from NSCM.</p>
</caption>
<graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.g005" position="float" xlink:type="simple"/>
</fig>
<p>Based on the simulation results, we chose F<sub>st</sub> for our study for the following reasons. First, the chi-square test and the ANOVA F-test were not appropriate for our data because of their dependence on sample size (<xref rid="pone.0119994.g002" ref-type="fig">Fig. 2A</xref>) and low specificity (<xref rid="pone.0119994.g003" ref-type="fig">Fig. 3</xref>); this would result in rejecting SNPs without population differences at large sample sizes. NCSM yielded the lowest sensitivity (<xref rid="pone.0119994.g004" ref-type="fig">Fig. 4</xref>). Therefore, we chose F<sub>st</sub> for its high specificity and sensitivity robust to sample size.</p>
</sec>
<sec id="sec009">
<title>4. GO analysis and pathway analysis: comparison of HD and LD gene groups with all genes in DAVID</title>
<p>In order to biologically interpret the HD and LD gene groups, we performed a GO analysis and pathway analysis. Eighteen terms were statistically significant when the HD gene group was analyzed independently, and 48 terms were significant when the LD gene group was analyzed independently. The separate analyses had 25 significant terms in common. <xref rid="pone.0119994.t003" ref-type="table">Table 3</xref> shows Benjamini-Hochberg’s q-values [<xref rid="pone.0119994.ref022" ref-type="bibr">22</xref>] and fold enrichments for GO terms and pathways that were statistically significant in the analysis of the HD gene group only. <xref rid="pone.0119994.t004" ref-type="table">Table 4</xref> shows the results for the LD gene group. When the LD gene group was used as input for the analysis (<xref rid="pone.0119994.t004" ref-type="table">Table 4</xref>), DR terms in GO categories “drug metabolic process,” “drug metabolism,” and “metabolism of xenobiotics by cytochrome P450” were significant. The term “drug binding” was the only significant DR term resulting from analysis of the HD gene group (<xref rid="pone.0119994.t003" ref-type="table">Table 3</xref>). From analysis of the HD gene group, several terms associated with cell communication had significant <italic>p</italic>-values (0.0006, 0.0002, and 0.0142) and high fold enrichments. In particular, the terms, “cell communication” and “cell-cell signaling” had the lowest <italic>p</italic>-values among the terms in <xref rid="pone.0119994.t003" ref-type="table">Table 3</xref>. However, in the LD gene group, only one significant term was related to cell communication (“regulation of cell communication”), which had a q-value (0.0273) and fold enrichment (2.41).</p>
<table-wrap id="pone.0119994.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.t003</object-id>
<label>Table 3</label> <caption><title>Q-values and fold enrichments of significant terms in HD group.</title></caption>
<alternatives>
<graphic id="pone.0119994.t003g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.t003" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Terms</th>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
<th align="left" rowspan="1" colspan="1">Terms</th>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Behavioral response to nicotine</td>
<td align="char" char="." rowspan="1" colspan="1">96.16</td>
<td align="char" char="." rowspan="1" colspan="1">0.0201</td>
<td align="left" rowspan="1" colspan="1">BP: Secretion</td>
<td align="char" char="." rowspan="1" colspan="1">5.24</td>
<td align="char" char="." rowspan="1" colspan="1">0.0466</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MF: Drug binding</td>
<td align="char" char="." rowspan="1" colspan="1">16.51</td>
<td align="char" char="." rowspan="1" colspan="1">0.0142</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation of cell differentiation</td>
<td align="char" char="." rowspan="1" colspan="1">4.56</td>
<td align="char" char="." rowspan="1" colspan="1">0.0157</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Adult behavior</td>
<td align="char" char="." rowspan="1" colspan="1">15.65</td>
<td align="char" char="." rowspan="1" colspan="1">0.0075</td>
<td align="left" rowspan="1" colspan="1">BP: Cell Communication</td>
<td align="char" char="." rowspan="1" colspan="1">4.53</td>
<td align="char" char="." rowspan="1" colspan="1">0.0002</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Regulation of multicellular organism growth</td>
<td align="char" char="." rowspan="1" colspan="1">14.71</td>
<td align="char" char="." rowspan="1" colspan="1">0.0465</td>
<td align="left" rowspan="1" colspan="1">BP: Cell development</td>
<td align="char" char="." rowspan="1" colspan="1">3.48</td>
<td align="char" char="." rowspan="1" colspan="1">0.0464</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CC: Dendrite</td>
<td align="char" char="." rowspan="1" colspan="1">9.63</td>
<td align="char" char="." rowspan="1" colspan="1">0.0027</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation of developmental process</td>
<td align="char" char="." rowspan="1" colspan="1">3.34</td>
<td align="char" char="." rowspan="1" colspan="1">0.0276</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Sex differentiation</td>
<td align="char" char="." rowspan="1" colspan="1">8.92</td>
<td align="char" char="." rowspan="1" colspan="1">0.0210</td>
<td align="left" rowspan="1" colspan="1">BP: Neurological system process</td>
<td align="char" char="." rowspan="1" colspan="1">3.15</td>
<td align="char" char="." rowspan="1" colspan="1">0.0060</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Development of primary sexual characteristics</td>
<td align="char" char="." rowspan="1" colspan="1">8.83</td>
<td align="char" char="." rowspan="1" colspan="1">0.0468</td>
<td align="left" rowspan="1" colspan="1">BP: Anatomical structure morphogenesis</td>
<td align="char" char="." rowspan="1" colspan="1">2.81</td>
<td align="char" char="." rowspan="1" colspan="1">0.0197</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Reproductive developmental process</td>
<td align="char" char="." rowspan="1" colspan="1">5.99</td>
<td align="char" char="." rowspan="1" colspan="1">0.0307</td>
<td align="left" rowspan="1" colspan="1">BP: Cell differentiation</td>
<td align="char" char="." rowspan="1" colspan="1">2.47</td>
<td align="char" char="." rowspan="1" colspan="1">0.0214</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Cell-cell signaling</td>
<td align="char" char="." rowspan="1" colspan="1">5.24</td>
<td align="char" char="." rowspan="1" colspan="1">0.0006</td>
<td align="left" rowspan="1" colspan="1">BP: System development</td>
<td align="char" char="." rowspan="1" colspan="1">2.21</td>
<td align="char" char="." rowspan="1" colspan="1">0.0136</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>FE: Fold enrichment</p></fn>
<fn id="t003fn002"><p>BH’s q: Benjamini-Hochberg’s q-value</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0119994.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.t004</object-id>
<label>Table 4</label> <caption><title>Q-values and fold enrichments of significant terms in LD group.</title></caption>
<alternatives>
<graphic id="pone.0119994.t004g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.t004" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th align="left" rowspan="1" colspan="1">Terms</th>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
<th align="left" rowspan="1" colspan="1">Terms</th>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Negative Regulation Of Amine Transport</td>
<td align="char" char="." rowspan="1" colspan="1">58.70</td>
<td align="char" char="." rowspan="1" colspan="1">0.0170</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Response To Stress</td>
<td align="char" char="." rowspan="1" colspan="1">5.71</td>
<td align="left" rowspan="1" colspan="1">0.0017</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">*BP: Drug Metabolic Process</td>
<td align="char" char="." rowspan="1" colspan="1">48.92</td>
<td align="char" char="." rowspan="1" colspan="1">0.0003</td>
<td align="left" rowspan="1" colspan="1">BP: Positive Regulation Of Transport</td>
<td align="char" char="." rowspan="1" colspan="1">5.62</td>
<td align="left" rowspan="1" colspan="1">0.0103</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Negative Regulation Of Glucose Transport</td>
<td align="char" char="." rowspan="1" colspan="1">46.96</td>
<td align="char" char="." rowspan="1" colspan="1">0.0253</td>
<td align="left" rowspan="1" colspan="1">CC: Membrane fraction</td>
<td align="char" char="." rowspan="1" colspan="1">5.33</td>
<td align="left" rowspan="1" colspan="1">4.4E-12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Negative Regulation Of Organic Acid Transport</td>
<td align="char" char="." rowspan="1" colspan="1">46.96</td>
<td align="char" char="." rowspan="1" colspan="1">0.0253</td>
<td align="left" rowspan="1" colspan="1">CC: Insoluble fraction</td>
<td align="char" char="." rowspan="1" colspan="1">5.31</td>
<td align="left" rowspan="1" colspan="1">3.0E-12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Multicellular Organismal Water Homeostasis</td>
<td align="char" char="." rowspan="1" colspan="1">42.69</td>
<td align="char" char="." rowspan="1" colspan="1">0.0281</td>
<td align="left" rowspan="1" colspan="1">BP: Heterocycle Metabolic Process</td>
<td align="char" char="." rowspan="1" colspan="1">5.16</td>
<td align="left" rowspan="1" colspan="1">0.0017</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Body Fluid Secretion</td>
<td align="char" char="." rowspan="1" colspan="1">28.99</td>
<td align="char" char="." rowspan="1" colspan="1">0.0011</td>
<td align="left" rowspan="1" colspan="1">BP: Positive Regulation Of Multicellular Organismal Process</td>
<td align="char" char="." rowspan="1" colspan="1">5.13</td>
<td align="left" rowspan="1" colspan="1">0.0144</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Negative Regulation Of Ion Transport</td>
<td align="char" char="." rowspan="1" colspan="1">27.23</td>
<td align="char" char="." rowspan="1" colspan="1">0.0082</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Anatomical Structure Morphogenesis</td>
<td align="char" char="." rowspan="1" colspan="1">5.00</td>
<td align="left" rowspan="1" colspan="1">0.0329</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MF: Oxygen Binding</td>
<td align="char" char="." rowspan="1" colspan="1">26.82</td>
<td align="char" char="." rowspan="1" colspan="1">0.0000</td>
<td align="left" rowspan="1" colspan="1">BP: Cellular Chemical Homeostasis</td>
<td align="char" char="." rowspan="1" colspan="1">4.94</td>
<td align="left" rowspan="1" colspan="1">0.0011</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Renal System Process</td>
<td align="char" char="." rowspan="1" colspan="1">22.36</td>
<td align="char" char="." rowspan="1" colspan="1">0.0126</td>
<td align="left" rowspan="1" colspan="1">CC: Cell projection part</td>
<td align="char" char="." rowspan="1" colspan="1">4.91</td>
<td align="left" rowspan="1" colspan="1">0.0173</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CC: Presynaptic membrane</td>
<td align="char" char="." rowspan="1" colspan="1">19.81</td>
<td align="char" char="." rowspan="1" colspan="1">0.0167</td>
<td align="left" rowspan="1" colspan="1">CC: Microsome</td>
<td align="char" char="." rowspan="1" colspan="1">4.85</td>
<td align="left" rowspan="1" colspan="1">0.0173</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Tube Size</td>
<td align="char" char="." rowspan="1" colspan="1">17.72</td>
<td align="char" char="." rowspan="1" colspan="1">0.0012</td>
<td align="left" rowspan="1" colspan="1">CC: Vesicular fraction</td>
<td align="char" char="." rowspan="1" colspan="1">4.71</td>
<td align="left" rowspan="1" colspan="1">0.0190</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KEGG: Linoleic acid metabolism</td>
<td align="char" char="." rowspan="1" colspan="1">14.24</td>
<td align="char" char="." rowspan="1" colspan="1">0.0306</td>
<td align="left" rowspan="1" colspan="1">KEGG: Calcium signaling pathway</td>
<td align="char" char="." rowspan="1" colspan="1">4.53</td>
<td align="left" rowspan="1" colspan="1">0.0217</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">*KEGG: Drug metabolism: other enzymes</td>
<td align="char" char="." rowspan="1" colspan="1">13.91</td>
<td align="char" char="." rowspan="1" colspan="1">0.0024</td>
<td align="left" rowspan="1" colspan="1">CC: Cell fraction</td>
<td align="char" char="." rowspan="1" colspan="1">4.51</td>
<td align="left" rowspan="1" colspan="1">3.1E-12</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KEGG: Arachidonic acid metabolism</td>
<td align="char" char="." rowspan="1" colspan="1">12.46</td>
<td align="char" char="." rowspan="1" colspan="1">0.0013</td>
<td align="left" rowspan="1" colspan="1">BP: Anatomical Structure Formation Involved In Morphogenesis</td>
<td align="char" char="." rowspan="1" colspan="1">4.00</td>
<td align="left" rowspan="1" colspan="1">0.0257</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">MF: Tetrapyrrole Binding</td>
<td align="char" char="." rowspan="1" colspan="1">11.49</td>
<td align="char" char="." rowspan="1" colspan="1">0.0000</td>
<td align="left" rowspan="1" colspan="1">BP: Transmembrane Transport</td>
<td align="char" char="." rowspan="1" colspan="1">3.85</td>
<td align="left" rowspan="1" colspan="1">0.0018</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KEGG: Retinol metabolism</td>
<td align="char" char="." rowspan="1" colspan="1">11.08</td>
<td align="char" char="." rowspan="1" colspan="1">0.0048</td>
<td align="left" rowspan="1" colspan="1">MF: Oxidoreductase Activity</td>
<td align="char" char="." rowspan="1" colspan="1">3.83</td>
<td align="left" rowspan="1" colspan="1">0.0002</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">*KEGG: Metabolism of xenobiotics by cytochrome P450</td>
<td align="char" char="." rowspan="1" colspan="1">9.97</td>
<td align="char" char="." rowspan="1" colspan="1">0.0060</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Response To Stimulus</td>
<td align="char" char="." rowspan="1" colspan="1">3.70</td>
<td align="left" rowspan="1" colspan="1">0.0124</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">*KEGG: Drug metabolism: cytochrome p450</td>
<td align="char" char="." rowspan="1" colspan="1">9.65</td>
<td align="char" char="." rowspan="1" colspan="1">0.0056</td>
<td align="left" rowspan="1" colspan="1">BP: Ion Transport</td>
<td align="char" char="." rowspan="1" colspan="1">3.67</td>
<td align="left" rowspan="1" colspan="1">0.0005</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Negative Regulation Of Multicellular Organismal Process</td>
<td align="char" char="." rowspan="1" colspan="1">8.59</td>
<td align="char" char="." rowspan="1" colspan="1">0.0006</td>
<td align="left" rowspan="1" colspan="1">BP: Positive Regulation Of Molecular Function</td>
<td align="char" char="." rowspan="1" colspan="1">3.47</td>
<td align="left" rowspan="1" colspan="1">0.0065</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Negative Regulation Of Transport</td>
<td align="char" char="." rowspan="1" colspan="1">8.12</td>
<td align="char" char="." rowspan="1" colspan="1">0.0051</td>
<td align="left" rowspan="1" colspan="1">BP: Homeostatic Process</td>
<td align="char" char="." rowspan="1" colspan="1">3.13</td>
<td align="left" rowspan="1" colspan="1">0.0055</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Response To External Stimulus</td>
<td align="char" char="." rowspan="1" colspan="1">7.88</td>
<td align="char" char="." rowspan="1" colspan="1">0.0019</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Multicellular Organismal Process</td>
<td align="char" char="." rowspan="1" colspan="1">3.01</td>
<td align="left" rowspan="1" colspan="1">0.0018</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Body Fluid Levels</td>
<td align="char" char="." rowspan="1" colspan="1">6.66</td>
<td align="char" char="." rowspan="1" colspan="1">0.0281</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Catalytic Activity</td>
<td align="char" char="." rowspan="1" colspan="1">2.78</td>
<td align="left" rowspan="1" colspan="1">0.0133</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Muscle System Process</td>
<td align="char" char="." rowspan="1" colspan="1">6.52</td>
<td align="char" char="." rowspan="1" colspan="1">0.0128</td>
<td align="left" rowspan="1" colspan="1">CC: Endomembrane system</td>
<td align="char" char="." rowspan="1" colspan="1">2.75</td>
<td align="left" rowspan="1" colspan="1">0.0169</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Angiogenesis</td>
<td align="char" char="." rowspan="1" colspan="1">6.35</td>
<td align="char" char="." rowspan="1" colspan="1">0.0317</td>
<td align="left" rowspan="1" colspan="1">BP: Regulation Of Cell Communication</td>
<td align="char" char="." rowspan="1" colspan="1">2.41</td>
<td align="left" rowspan="1" colspan="1">0.0273</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>FE: Fold enrichment</p></fn>
<fn id="t004fn002"><p>BH’s q: Benjamini-Hochberg’s q-value</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Seventeen genes were associated with the three terms related to cell communication (“cell-cell signaling,” “cell communication,” and “drug binding”). Among these 17 genes, we extracted five that contained SNPs with F<sub>st</sub> values greater than 0.5: <italic>STX4</italic>, <italic>PPARD</italic>, <italic>DCK</italic>, <italic>GRIK4</italic>, <italic>and DRD3</italic> contained SNPs rs10871454, rs6922548, rs3775289, rs1954787, and rs167771 with F<sub>st</sub> values of 0.682, 0.620, 0.573, 0.531, and 0.510, respectively.</p>
<p>Syntaxin 4 (STX4) is a component of the SNARE complex, which mediates docking of cellular transport vesicles. In a GWAS, rs10871454 in <italic>STX4</italic> accounted for over 25% of the variance in log-transformed stabilized warfarin dose and was in perfect linkage disequilibrium with rs9923231 [<xref rid="pone.0119994.ref033" ref-type="bibr">33</xref>].</p>
<p>PPARs are nuclear hormone receptors that bind peroxisome proliferators and control the size and number of peroxisomes produced by cells. In particular, PPARδ is a receptor that binds peroxisome proliferators such as hypo-lipidemic drugs and fatty acids [<xref rid="pone.0119994.ref034" ref-type="bibr">34</xref>]. The SNP rs6922548 in <italic>PPARδ</italic> is also associated with positive clinical response to docetaxel and thalidomide [<xref rid="pone.0119994.ref035" ref-type="bibr">35</xref>].</p>
<p>DCK is involved in the gemcitabine and lamivudine pathways [<xref rid="pone.0119994.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0119994.ref037" ref-type="bibr">37</xref>]. It also participates in the phosphorylation of cytosolic nucleosides by deoxycytidine kinase and pyrimidine salvage reactions. Fukunaga <italic>et al</italic>. examined variants that were identified from a screen of 13 genes in the gemcitabine metabolic pathway [<xref rid="pone.0119994.ref038" ref-type="bibr">38</xref>] and found that the C allele of SNP rs3775289 was not present among Europeans or Africans in their study. However, in the International HapMap Data, the allelic frequencies of the C allele are 0.929 in Europeans and 0.279 in Africans.</p>
<p>Paddock <italic>et al</italic>. implemented an association study based on the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) cohort and found that rs1954787 in the <italic>GRIK4</italic> gene, which encodes the kainic acid-type glutamate receptor KA1, was associated with response to the antidepressant citalopram [<xref rid="pone.0119994.ref039" ref-type="bibr">39</xref>]. Accordingly, they suggested that the glutamate system plays an important role in modulating response to selective serotonin reuptake inhibitors (SSRIs). In addition, Pickard <italic>et al</italic>. showed that variation in <italic>GRIK4</italic> was significantly associated with both an increased risk of schizophrenia and a decreased risk of bipolar disorder [<xref rid="pone.0119994.ref040" ref-type="bibr">40</xref>]. Furthermore, the G variant of SNP rs167771 in <italic>DRD3</italic> was associated with an increased risk of extrapyramidal symptoms (EPS) in psychiatric patients receiving risperidone [<xref rid="pone.0119994.ref041" ref-type="bibr">41</xref>].</p>
<p>Several terms related to reproduction were identified in the analysis of the HD gene group, but none were identified in the analysis of the LD gene group. For example, <xref rid="pone.0119994.t003" ref-type="table">Table 3</xref> reports the terms “sex differentiation,” “development of primary sexual characteristics,” and “reproductive developmental process.” Similarly, Wu and Zhang reported that reproduction-associated processes (<italic>e</italic>.<italic>g</italic>., “sperm motility,” “spermatid development,” and “gamete generation”) had higher levels of PD [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>]. The criteria for HD genes in the present study were more robust than those for genes with higher levels of PD used by Wu and Zhang. Nevertheless, <xref rid="pone.0119994.t003" ref-type="table">Table 3</xref> reports several terms also identified by Wu and Zhang [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>]. For example, terms related to the nervous system (“dendrite” and “neurological system process”), development (“anatomical structure morphogenesis,” “regulation of developmental process,” “system development,” and “cell development”), stress response, homeostasis, growth (“regulation of multicellular organism growth”), secretion (“secretion”), and metabolism had high levels of PD.</p>
<p>The term “behavioral response to nicotine” had the highest fold enrichment of 96.16 (<xref rid="pone.0119994.t003" ref-type="table">Table 3</xref>). This was likely due to the large number of nicotine-related SNPs in our dataset. Specifically, 97 of 654 SNPs were associated with nicotine according to the annotation provided by PharmGKB. The term “adult behavior,” which had a high fold enrichment (15.65) and low <italic>p</italic>-value (0.0075), is an ancestor term of “behavioral response to nicotine.”</p>
<p>Two terms were associated with differentiation in <xref rid="pone.0119994.t003" ref-type="table">Table 3</xref>. “Regulation of cell differentiation” and “cell differentiation” showed fold enrichments of 4.56 and 2.47 and q-values of 0.0157 and 0.0214, respectively.</p>
</sec>
<sec id="sec010">
<title>5. GO analysis and pathway analysis: comparison to DR genes</title>
<p>We performed GO analysis and pathway analysis in order to biologically interpret the relationship between the HD gene group and DR genes. The results are summarized as q-values using Benjamini-Hochberg’s method [<xref rid="pone.0119994.ref041" ref-type="bibr">41</xref>] and fold enrichments of the GO terms and pathways. A Benjamini-Hochberg’s q-value less than 0.05 indicates that the HD group contained significantly more genes in the term as compared to randomly selected DR genes.</p>
<p><xref rid="pone.0119994.t005" ref-type="table">Table 5</xref> shows the results from the GO analysis and pathway analysis comparing the HD gene group and DR genes. The resulting terms included those related to reproduction that were included in <xref rid="pone.0119994.t003" ref-type="table">Table 3</xref>: “sex differentiation,” “development of primary sexual characteristics,” “reproductive structure development,” “gonad development,” and “development of primary sexual characteristics.”</p>
<table-wrap id="pone.0119994.t005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0119994.t005</object-id>
<label>Table 5</label> <caption><title>Q-values and fold enrichments of hypergeometric test between HD group and drug-related (DR) genes.</title></caption>
<alternatives>
<graphic id="pone.0119994.t005g" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0119994.t005" xlink:type="simple"/>
<table>
<colgroup span="1">
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
<col align="left" valign="middle" span="1"/>
</colgroup>
<thead>
<tr>
<th rowspan="2" align="left" colspan="1">Terms</th>
<th colspan="2" align="center" rowspan="1">HD vs. others</th>
<th colspan="2" align="center" rowspan="1">DR vs. others</th>
<th colspan="2" align="center" rowspan="1">HD vs DR</th>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
<th align="left" rowspan="1" colspan="1">FE</th>
<th align="left" rowspan="1" colspan="1">BH’s q</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Sex Differentiation</td>
<td align="char" char="." rowspan="1" colspan="1">8.92</td>
<td align="char" char="." rowspan="1" colspan="1">0.0210</td>
<td align="char" char="." rowspan="1" colspan="1">2.52</td>
<td align="char" char="." rowspan="1" colspan="1">0.2015</td>
<td align="char" char="." rowspan="1" colspan="1">3.54</td>
<td align="char" char="." rowspan="1" colspan="1">0.0158</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Development Of Primary Sexual Characteristics</td>
<td align="char" char="." rowspan="1" colspan="1">8.83</td>
<td align="char" char="." rowspan="1" colspan="1">0.0468</td>
<td align="char" char="." rowspan="1" colspan="1">2.57</td>
<td align="char" char="." rowspan="1" colspan="1">0.2558</td>
<td align="char" char="." rowspan="1" colspan="1">3.44</td>
<td align="char" char="." rowspan="1" colspan="1">0.0283</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Reproductive structure development</td>
<td align="char" char="." rowspan="1" colspan="1">8.90</td>
<td align="char" char="." rowspan="1" colspan="1">0.0504</td>
<td align="char" char="." rowspan="1" colspan="1">2.58</td>
<td align="char" char="." rowspan="1" colspan="1">0.2531</td>
<td align="char" char="." rowspan="1" colspan="1">3.44</td>
<td align="char" char="." rowspan="1" colspan="1">0.0283</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Gonad development</td>
<td align="char" char="." rowspan="1" colspan="1">9.74</td>
<td align="char" char="." rowspan="1" colspan="1">0.1139</td>
<td align="char" char="." rowspan="1" colspan="1">2.81</td>
<td align="char" char="." rowspan="1" colspan="1">0.3622</td>
<td align="char" char="." rowspan="1" colspan="1">3.47</td>
<td align="char" char="." rowspan="1" colspan="1">0.0527</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BP: Development Of Primary Sexual Characteristics</td>
<td align="char" char="." rowspan="1" colspan="1">8.83</td>
<td align="char" char="." rowspan="1" colspan="1">0.0468</td>
<td align="char" char="." rowspan="1" colspan="1">2.57</td>
<td align="char" char="." rowspan="1" colspan="1">0.2558</td>
<td align="char" char="." rowspan="1" colspan="1">3.47</td>
<td align="char" char="." rowspan="1" colspan="1">0.0527</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">KEGG: Wnt signaling pathway</td>
<td align="char" char="." rowspan="1" colspan="1">3.45</td>
<td align="char" char="." rowspan="1" colspan="1">0.6823</td>
<td align="char" char="." rowspan="1" colspan="1">1.32</td>
<td align="char" char="." rowspan="1" colspan="1">0.8715</td>
<td align="char" char="." rowspan="1" colspan="1">2.62</td>
<td align="char" char="." rowspan="1" colspan="1">0.0556</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t005fn001"><p>FE: Fold enrichment</p></fn>
<fn id="t005fn002"><p>BH’s q: Benjamini-Hochberg’s q-value</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Since Wu and Zhang [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>] did not conduct a pathway analysis, the “Wnt signaling pathway” was not directly identified. However, their GO analysis identified the term “Wnt receptor signaling pathway through beta-catenin” as statistically significant in the HD gene group [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>]. The Wnt signaling pathway is important in pharmacogenetics, because it is strongly associated with cancer [<xref rid="pone.0119994.ref042" ref-type="bibr">42</xref>,<xref rid="pone.0119994.ref043" ref-type="bibr">43</xref>]. Further studies are warranted to identify drugs that inhibit the Wnt signaling pathway, because inhibition of aberrant Wnt signaling in cancer cell lines inhibits their growth [<xref rid="pone.0119994.ref044" ref-type="bibr">44</xref>].</p>
</sec>
</sec>
<sec id="sec011" sec-type="conclusions">
<title>Discussion</title>
<p>PD is important for understanding differences in drug responses among populations. However, PD often refers to the distance between two different subpopulations; therefore, several studies have investigated approaches for averaging the PD of each SNP. For instance, the impact of SNP ascertainment on estimating the distance between subpopulations has already been reported [<xref rid="pone.0119994.ref045" ref-type="bibr">45</xref>]. In contrast, the present study identified population-specific pharmacogenomics variants. We did not focus on identifying average distances using all SNPs; rather, we used each SNP to identify population-specific pharmacogenomics variants. As a result, our results described the impact of sample ascertainment on different measures of PD for each SNP. In addition, the present study investigated PD of genes in the PharmGKB database, while several previous studies have focused on genes related to individual drugs [<xref rid="pone.0119994.ref005" ref-type="bibr">5</xref>]. This approach enabled us to more systematically study PD of DR genes by considering all reported DR genes from PharmGKB.</p>
<p>In our comparison study, F<sub>st</sub> showed high specificity and sensitivity robust to the different sample sizes of HapMap release 27. After calculating F<sub>st</sub> from the allele frequency data of each SNP, we defined HD and LD gene groups. Then, we performed GO analysis and pathway analysis to describe the biological characteristics of the HD gene group. We compared the HD gene group to two different backgrounds: all genes in DAVID and DR genes in the PharmGKB database.</p>
<p>The GO and pathway analyses identified two terms related to cell communication (“cell-cell signaling” and “cell communication”), which had the lowest <italic>p</italic>-values (0.0006 and 0.0002, respectively). In addition, the term “drug binding,” which was related to cell communication, was also considered to be meaningful due to its high fold enrichment (16.51) despite its moderate <italic>p</italic>-value (0.0142). Thus, these results suggest that the HD gene group from PharmGKB is highly associated with cell communication. Since drug binding is associated with the cell membrane, similar to processes related to both cell-cell signaling and cell communication, the simultaneous identification of these GO terms is convincing. In addition, this finding suggests that the cellular location of gene products affects PD. It is possible that, the outer surface of the cell membrane is initially affected by mutagens, because it is closest to the extracellular environment.</p>
<p>In addition, we examined genes containing SNPs with high F<sub>st</sub> values (above 0.5) among cell-communication-related terms, such as <italic>STX4</italic>, <italic>PPARD</italic>, <italic>DCK</italic>, <italic>GRIK4</italic>, and <italic>DRD3</italic>. Specifically, SNPs rs10871454, rs6922548, rs3775289, rs1954787, and rs167771 had F<sub>st</sub> values of 0.682, 0.620, 0.573, 0.531, and 0.510, respectively. Further biological studies of these genes will help elucidate their roles in pharmacogenetics.</p>
<p>Unlike other GO analyses, we employed DR genes from PharmGKB and performed an additional analysis by using them as a background for the GO analysis. This strategy of changing the background of the GO analysis from all genes to DR genes represents a novel method. Therefore, our approach has the advantage of providing distinct information about genes of interest by altering the background of analysis.</p>
<p>There are several similarities and differences between the PD study of Wu and Zhang [<xref rid="pone.0119994.ref001" ref-type="bibr">1</xref>] and the present study. Both studies determined PD using F<sub>st</sub> and investigated characteristics of genes with a high level of differentiation by GO analysis. Thus, the studies identified several similar terms such as those related to replication, development, and metabolism. In addition to the HD gene group, our study performed GO analysis of the LD gene group and compared the results, which identified distinct characteristics of each group. We also conducted GO and pathway analyses comparing the HD gene group to DR genes and identified two meaningful terms, “drug binding” and “Wnt signaling pathway,” which were not identified by Wu and Zhang.</p>
<p>In conclusion, the present study describes an approach for assessing PD associated with multiple drugs using a database. Therefore, the integrated approach may identify valid genetic features different from the background gene list. We validated results from other systematic analyses. Moreover, our approach allows the possibility of improving the results. DR genes that are unknown or newly reported were not included in the present study. Thus, our approach may be limited in its ability to interpret the population-specific difference in drug response or efficacy caused by genetic divergence. However, this method remains convincing, because our statistical analyses revealed high specificity and sensitivity robust to sample size. Furthermore, we obtained significant differences from other DR genes in the PharmGKB database, and our approach thus represents a systematic method for identifying valid population-specific pharmacogenomics variants.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0119994.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>DD</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>YP</given-names></name> (<year>2011</year>) <article-title>Different level of population differentiation among human genes</article-title>. <source>Bmc Evolutionary Biology</source> <volume>11</volume>.</mixed-citation></ref>
<ref id="pone.0119994.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Myles</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Davison</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Barrett</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Stoneking</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Timpson</surname> <given-names>N</given-names></name> (<year>2008</year>) <article-title>Worldwide population differentiation at disease-associated SNPs</article-title>. <source>Bmc Medical Genomics</source> <volume>1</volume>.</mixed-citation></ref>
<ref id="pone.0119994.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barreiro</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Laval</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Quach</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Patin</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Quintana-Murci</surname> <given-names>L</given-names></name> (<year>2008</year>) <article-title>Natural selection has driven population differentiation in modern humans</article-title>. <source>Nature Genetics</source> <volume>40</volume>: <fpage>340</fpage>–<lpage>345</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.78" xlink:type="simple">10.1038/ng.78</ext-link></comment> <object-id pub-id-type="pmid">18246066</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wilson</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Weale</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Gratrix</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Fletcher</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Population genetic structure of variable drug response</article-title>. <source>Nature Genetics</source> <volume>29</volume>: <fpage>265</fpage>–<lpage>269</lpage>. <object-id pub-id-type="pmid">11685208</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gage</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Lesko</surname> <given-names>LJ</given-names></name> (<year>2008</year>) <article-title>Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues</article-title>. <source>Journal of Thrombosis and Thrombolysis</source> <volume>25</volume>: <fpage>45</fpage>–<lpage>51</lpage>. <object-id pub-id-type="pmid">17906972</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wilkinson</surname> <given-names>GR</given-names></name>, <name name-style="western"><surname>Caraco</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Muszkat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Kashima</surname> <given-names>T</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients</article-title>. <source>Clinical Pharmacology &amp; Therapeutics</source> <volume>73</volume>: <fpage>253</fpage>–<lpage>263</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pavani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Naushad</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Rupasree</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>TR</given-names></name>, <name name-style="western"><surname>Malempati</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Pinjala</surname> <given-names>RK</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Optimization of warfarin dose by population-specific pharmacogenomic algorithm</article-title>. <source>Pharmacogenomics Journal</source> <volume>12</volume>: <fpage>306</fpage>–<lpage>311</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/tpj.2011.4" xlink:type="simple">10.1038/tpj.2011.4</ext-link></comment> <object-id pub-id-type="pmid">21358752</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Duan</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Bleibel</surname> <given-names>WK</given-names></name>, <name name-style="western"><surname>Kistner</surname> <given-names>EO</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>TA</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>104</volume>: <fpage>9758</fpage>–<lpage>9763</lpage>. <object-id pub-id-type="pmid">17537913</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">International HapMap Consortium</collab>, <name name-style="western"><surname>Frazer</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Ballinger</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Cox</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Hinds</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Stuve</surname> <given-names>LL</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>A second generation human haplotype map of over 3.1 million SNPs</article-title>. <source>Nature</source> <volume>449</volume>: <fpage>851</fpage>–<lpage>861</lpage>. <object-id pub-id-type="pmid">17943122</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whirl-Carrillo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>McDonagh</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Hebert</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Gong</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Sangkuhl</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Thorn</surname> <given-names>CF</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Pharmacogenomics knowledge for personalized medicine</article-title>. <source>Clin Pharmacol Ther</source> <volume>92</volume>: <fpage>414</fpage>–<lpage>417</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/clpt.2012.96" xlink:type="simple">10.1038/clpt.2012.96</ext-link></comment> <object-id pub-id-type="pmid">22992668</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hewett</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Oliver</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Rubin</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Easton</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Stuart</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>RB</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>PharmGKB: The Pharmacogenetics Knowledge Base</article-title>. <source>Nucleic Acids Research</source> <volume>30</volume>: <fpage>163</fpage>–<lpage>165</lpage>. <object-id pub-id-type="pmid">11752281</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Joubert</surname> <given-names>BR</given-names></name>, <name name-style="western"><surname>North</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>YF</given-names></name>, <name name-style="western"><surname>Mwapasa</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Franceschini</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Meshnick</surname> <given-names>SR</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Comparison of genome-wide variation between Malawians and African ancestry HapMap populations</article-title>. <source>Journal of Human Genetics</source> <volume>55</volume>: <fpage>366</fpage>–<lpage>374</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jhg.2010.41" xlink:type="simple">10.1038/jhg.2010.41</ext-link></comment> <object-id pub-id-type="pmid">20485449</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akey</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Shriver</surname> <given-names>MD</given-names></name> (<year>2002</year>) <article-title>Interrogating a high-density SNP map for signatures of natural selection</article-title>. <source>Genome Research</source> <volume>12</volume>: <fpage>1805</fpage>–<lpage>1814</lpage>. <object-id pub-id-type="pmid">12466284</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weir</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Cockerham</surname> <given-names>CC</given-names></name> (<year>1984</year>) <article-title>Estimating F-Statistics for the Analysis of Population-Structure</article-title>. <source>Evolution</source> <volume>38</volume>: <fpage>1358</fpage>–<lpage>1370</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weir</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Hill</surname> <given-names>WG</given-names></name> (<year>2002</year>) <article-title>Estimating F-statistics</article-title>. <source>Annual Review of Genetics</source> <volume>36</volume>: <fpage>721</fpage>–<lpage>750</lpage>. <object-id pub-id-type="pmid">12359738</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Voight</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Kudaravalli</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wen</surname> <given-names>XQ</given-names></name>, <name name-style="western"><surname>Pritchard</surname> <given-names>JK</given-names></name> (<year>2006</year>) <article-title>A map of recent positive selection in the human genome</article-title>. <source>Plos Biology</source> <volume>4</volume>: <fpage>446</fpage>–<lpage>458</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Casto</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Feldman</surname> <given-names>MW</given-names></name> (<year>2011</year>) <article-title>Genome-wide association study SNPs in the human genome diversity project populations: does selection affect unlinked SNPs with shared trait associations?</article-title> <source>PLoS Genet</source> <volume>7</volume>: <fpage>e1001266</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1001266" xlink:type="simple">10.1371/journal.pgen.1001266</ext-link></comment> <object-id pub-id-type="pmid">21253569</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>YS</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>D</given-names></name> (<year>2007</year>) <article-title>SNP@Ethnos: a database of ethnically variant single-nucleotide polymorphisms</article-title>. <source>Nucleic Acids Res</source> <volume>35</volume>: <fpage>D711</fpage>–<lpage>D715</lpage>. <object-id pub-id-type="pmid">17135185</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tibshirani</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hastie</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Narasimhan</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>G</given-names></name> (<year>2002</year>) <article-title>Diagnosis of multiple cancer types by shrunken centroids of gene expression</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>99</volume>: <fpage>6567</fpage>–<lpage>6572</lpage>. <object-id pub-id-type="pmid">12011421</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>T</given-names></name> (<year>2010</year>) <source>Unbalanced sample size effect on the genome-wide population differentiation studies</source>; pp. <fpage>347</fpage>–<lpage>352</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferrer-Admetlla</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Liang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Korneliussen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>R</given-names></name> (<year>2014</year>) <article-title>On Detecting Incomplete Soft or Hard Selective Sweeps Using Haplotype Structure</article-title>. <source>Molecular Biology and Evolution</source>.</mixed-citation></ref>
<ref id="pone.0119994.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Benjamini</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hochberg</surname> <given-names>Y</given-names></name> (<year>1995</year>) <article-title>Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing</article-title>. <source>Journal of the Royal Statistical Society Series B-Methodological</source> <volume>57</volume>: <fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>YM</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Shu</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Meng</surname> <given-names>FJ</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>YM</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Genome-wide identification of osmotic stress response gene in Arabidopsis thaliana</article-title>. <source>Genomics</source> <volume>92</volume>: <fpage>488</fpage>–<lpage>493</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ygeno.2008.08.011" xlink:type="simple">10.1016/j.ygeno.2008.08.011</ext-link></comment> <object-id pub-id-type="pmid">18804526</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref024"><label>24</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Wright</surname> <given-names>S</given-names></name> (<year>1978</year>) <chapter-title>Evolution and the genetics of populations</chapter-title>. <publisher-loc>Chicago</publisher-loc>: <publisher-name>University of Chicago Press</publisher-name>.</mixed-citation></ref>
<ref id="pone.0119994.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cardoso</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Provan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Powell</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ferreira</surname> <given-names>PCG</given-names></name>, <name name-style="western"><surname>De Oliveira</surname> <given-names>DE</given-names></name> (<year>1998</year>) <article-title>High genetic differentiation among remnant populations of the endangered Caesalpinia echinata Lam. (Leguminosae-Caesalpinioideae)</article-title>. <source>Molecular Ecology</source> <volume>7</volume>: <fpage>601</fpage>–<lpage>608</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strauss</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>YP</given-names></name>, <name name-style="western"><surname>Hipkins</surname> <given-names>VD</given-names></name> (<year>1993</year>) <article-title>High-Levels of Population Differentiation for Mitochondrial-DNA Haplotypes in Pinus-Radiata, Muricata, and Attenuata</article-title>. <source>Theoretical and Applied Genetics</source> <volume>86</volume>: <fpage>605</fpage>–<lpage>611</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/BF00838716" xlink:type="simple">10.1007/BF00838716</ext-link></comment> <object-id pub-id-type="pmid">24193710</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Cox</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Dolan</surname> <given-names>ME</given-names></name> (<year>2008</year>) <article-title>FstSNP-HapMap3: a database of SNPs with high population differentiation for HapMap3</article-title>. <source>Bioinformation</source> <volume>3</volume>: <fpage>139</fpage>–<lpage>141</lpage>. <object-id pub-id-type="pmid">19238253</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sherman</surname> <given-names>BT</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>QN</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Bour</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>D</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis</article-title>. <source>Bmc Bioinformatics</source> <volume>8</volume>.</mixed-citation></ref>
<ref id="pone.0119994.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ashburner</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ball</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Blake</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Botstein</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Butler</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cherry</surname> <given-names>JM</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Gene Ontology: tool for the unification of biology</article-title>. <source>Nature Genetics</source> <volume>25</volume>: <fpage>25</fpage>–<lpage>29</lpage>. <object-id pub-id-type="pmid">10802651</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanehisa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Goto</surname> <given-names>S</given-names></name> (<year>2000</year>) <article-title>KEGG: Kyoto Encyclopedia of Genes and Genomes</article-title>. <source>Nucleic Acids Research</source> <volume>28</volume>: <fpage>27</fpage>–<lpage>30</lpage>. <object-id pub-id-type="pmid">10592173</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><collab xlink:type="simple">International HapMap 3 Consortium</collab>, <name name-style="western"><surname>Altshuler</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Gibbs</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Peltonen</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Altshuler</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Gibbs</surname> <given-names>RA</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Integrating common and rare genetic variation in diverse human populations</article-title>. <source>Nature</source> <volume>467</volume>: <fpage>52</fpage>–<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature09298" xlink:type="simple">10.1038/nature09298</ext-link></comment> <object-id pub-id-type="pmid">20811451</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>IW</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>KI</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Yeon</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bang</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>TS</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Ethnic variability in the allelic distribution of pharmacogenes between Korean and other populations</article-title>. <source>Pharmacogenetics and Genomics</source> <volume>22</volume>: <fpage>829</fpage>–<lpage>836</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/FPC.0b013e328358dd70" xlink:type="simple">10.1097/FPC.0b013e328358dd70</ext-link></comment> <object-id pub-id-type="pmid">22955668</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Teichert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eijgelsheim</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Uitterlinden</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Buhre</surname> <given-names>PN</given-names></name>, <name name-style="western"><surname>Hofman</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>De-Smet</surname> <given-names>PAGM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genes</article-title>. <source>Pharmacogenetics and Genomics</source> <volume>21</volume>: <fpage>26</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/FPC.0b013e32834154fb" xlink:type="simple">10.1097/FPC.0b013e32834154fb</ext-link></comment> <object-id pub-id-type="pmid">21063236</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Law</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Knox</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Djoumbou</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Jewison</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2014</year>) <article-title>DrugBank 4.0: shedding new light on drug metabolism</article-title>. <source>Nucleic Acids Res</source> <volume>42</volume>: <fpage>1091</fpage>–<lpage>1097</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deeken</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Cormier</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>DK</given-names></name>, <name name-style="western"><surname>Sissung</surname> <given-names>TM</given-names></name>, <name name-style="western"><surname>Steinberg</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Tran</surname> <given-names>K</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform</article-title>. <source>Pharmacogenomics Journal</source> <volume>10</volume>: <fpage>191</fpage>–<lpage>199</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/tpj.2009.57" xlink:type="simple">10.1038/tpj.2009.57</ext-link></comment> <object-id pub-id-type="pmid">20038957</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kroep</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Loves</surname> <given-names>WJP</given-names></name>, <name name-style="western"><surname>van der Wilt</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Alvarez</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Talianidis</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Boven</surname> <given-names>E</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Pretreatment Deoxycytidine Kinase Levels Predict in Vivo Gemcitabine Sensitivity 1 Supported by Eli Lilly &amp; Co, International and The Netherlands.1</article-title>. <source>Molecular Cancer Therapeutics</source> <volume>1</volume>: <fpage>371</fpage>–<lpage>376</lpage>. <object-id pub-id-type="pmid">12477049</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kewn</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hoggard</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sales</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Back</surname> <given-names>DJ</given-names></name> (<year>2001</year>) <article-title>The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells</article-title>. <source>British Journal of Clinical Pharmacology</source> <volume>50</volume>: <fpage>597</fpage>–<lpage>604</lpage>.</mixed-citation></ref>
<ref id="pone.0119994.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukunaga</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Marsh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Murry</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Hurley</surname> <given-names>TD</given-names></name>, <name name-style="western"><surname>McLeod</surname> <given-names>HL</given-names></name> (<year>2004</year>) <article-title>Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway</article-title>. <source>Pharmacogenomics Journal</source> <volume>4</volume>: <fpage>307</fpage>–<lpage>314</lpage>. <object-id pub-id-type="pmid">15224082</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Paddock</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Laje</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Charney</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Rush</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Sorant</surname> <given-names>AJM</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort</article-title>. <source>American Journal of Psychiatry</source> <volume>164</volume>: <fpage>1181</fpage>–<lpage>1188</lpage>. <object-id pub-id-type="pmid">17671280</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pickard</surname> <given-names>BS</given-names></name>, <name name-style="western"><surname>Knight</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Hamilton</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Soares</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Boyd</surname> <given-names>JFK</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>A common variant in the 3' UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>105</volume>: <fpage>14940</fpage>–<lpage>14945</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0800643105" xlink:type="simple">10.1073/pnas.0800643105</ext-link></comment> <object-id pub-id-type="pmid">18824690</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gasso</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mas</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bernardo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Alvarez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Parellada</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lafuente</surname> <given-names>A</given-names></name>. (<year>2009</year>) <article-title>A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms</article-title>. <source>Pharmacogenomics Journal</source> <volume>9</volume>: <fpage>404</fpage>–<lpage>410</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/tpj.2009.26" xlink:type="simple">10.1038/tpj.2009.26</ext-link></comment> <object-id pub-id-type="pmid">19506579</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garber</surname> <given-names>K</given-names></name> (<year>2009</year>) <article-title>Drugging the Wnt Pathway: Problems And Progress</article-title>. <source>Journal of the National Cancer Institute</source> <volume>101</volume>: <fpage>548</fpage>–<lpage>550</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jnci/djp084" xlink:type="simple">10.1093/jnci/djp084</ext-link></comment> <object-id pub-id-type="pmid">19351922</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takahashi-Yanaga</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Sasaguri</surname> <given-names>T</given-names></name> (<year>2007</year>) <article-title>The Wnt/beta-catenin signaling pathway as a target in drug discovery</article-title>. <source>Journal of Pharmacological Sciences</source> <volume>104</volume>: <fpage>293</fpage>–<lpage>302</lpage>. <object-id pub-id-type="pmid">17721040</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barker</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Clevers</surname> <given-names>H</given-names></name> (<year>2006</year>) <article-title>Mining the Wnt pathway for cancer therapeutics</article-title>. <source>Nature Reviews Drug Discovery</source> <volume>5</volume>: <fpage>997</fpage>–<lpage>1014</lpage>. <object-id pub-id-type="pmid">17139285</object-id></mixed-citation></ref>
<ref id="pone.0119994.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bhatia</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Patterson</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sankararaman</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Price</surname> <given-names>AL</given-names></name> (<year>2013</year>) <article-title>Estimating and interpreting FST: The impact of rare variants</article-title>. <source>Genome Research</source> <volume>23</volume>: <fpage>1514</fpage>–<lpage>1521</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gr.154831.113" xlink:type="simple">10.1101/gr.154831.113</ext-link></comment> <object-id pub-id-type="pmid">23861382</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>